Aspira Womens Ownership

AWH Stock  USD 0.38  0.02  5.73%   
Aspira Womens holds a total of 17.53 Million outstanding shares. Aspira Womens Health retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2000-03-31
Previous Quarter
12.5 M
Current Value
15.4 M
Avarage Shares Outstanding
2.9 M
Quarterly Volatility
3.5 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Some institutional investors establish a significant position in stocks such as Aspira Womens in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Aspira Womens, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aspira Womens Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

Aspira Stock Ownership Analysis

About 31.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.15. Aspira Womens Health last dividend was issued on the 16th of December 2016. The entity had 1:15 split on the 12th of May 2023. Aspira Womens Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. Aspira Womens Health Inc. was incorporated in 1993 and is headquartered in Austin, Texas. Aspira Womans operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 106 people. For more info on Aspira Womens Health please contact Nicole CPA at 512 519 0400 or go to https://aspirawh.com.
Besides selling stocks to institutional investors, Aspira Womens also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Aspira Womens' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Aspira Womens' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Aspira Womens Quarterly Liabilities And Stockholders Equity

4.76 Million

About 31.0% of Aspira Womens Health are currently held by insiders. Unlike Aspira Womens' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Aspira Womens' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Aspira Womens' insider trades

Aspira Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Aspira Womens is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aspira Womens Health backward and forwards among themselves. Aspira Womens' institutional investor refers to the entity that pools money to purchase Aspira Womens' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
State Street Corp2024-09-30
19.7 K
Millennium Management Llc2024-09-30
16 K
Pnc Financial Services Group Inc2024-09-30
15 K
M&t Bank Corp2024-09-30
15 K
Virtu Financial Llc2024-09-30
12.6 K
Tower Research Capital Llc2024-09-30
K
Jpmorgan Chase & Co2024-09-30
2.1 K
Ubs Group Ag2024-09-30
1.8 K
Morgan Stanley - Brokerage Accounts2024-09-30
1.6 K
Armistice Capital, Llc2024-09-30
1.3 M
National Asset Management Inc2024-09-30
316.3 K
Note, although Aspira Womens' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Aspira Womens Health Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Aspira Womens insiders, such as employees or executives, is commonly permitted as long as it does not rely on Aspira Womens' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Aspira Womens insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Aspira Womens Outstanding Bonds

Aspira Womens issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Aspira Womens Health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Aspira bonds can be classified according to their maturity, which is the date when Aspira Womens Health has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Currently Active Assets on Macroaxis

When determining whether Aspira Womens Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aspira Womens' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aspira Womens Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aspira Womens Health Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aspira Womens Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aspira Womens. If investors know Aspira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aspira Womens listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.15)
Revenue Per Share
0.801
Quarterly Revenue Growth
(0.03)
Return On Assets
(1.86)
Return On Equity
(7.23)
The market value of Aspira Womens Health is measured differently than its book value, which is the value of Aspira that is recorded on the company's balance sheet. Investors also form their own opinion of Aspira Womens' value that differs from its market value or its book value, called intrinsic value, which is Aspira Womens' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aspira Womens' market value can be influenced by many factors that don't directly affect Aspira Womens' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aspira Womens' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aspira Womens is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aspira Womens' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.